Interestingly, both in acquired brain lesions such as ischemic stroke as well as progressive neurodegenerative disorders such as Alzheimer’s disease (AD), a recent study in PD showed that CCL23 levels were elevated compared to healthy controls and it predicted a steeper cognitive decline in AD patients [13,30]. The gene discussed is CCL23; the disease is Mental deterioration.